DK0527821T3 - Oxidationsresistente thrombomodulinanaloger - Google Patents

Oxidationsresistente thrombomodulinanaloger

Info

Publication number
DK0527821T3
DK0527821T3 DK91908593.6T DK91908593T DK0527821T3 DK 0527821 T3 DK0527821 T3 DK 0527821T3 DK 91908593 T DK91908593 T DK 91908593T DK 0527821 T3 DK0527821 T3 DK 0527821T3
Authority
DK
Denmark
Prior art keywords
analogs
oxidation
thrombomodulin
thrombomodulin analogues
resistant thrombomodulin
Prior art date
Application number
DK91908593.6T
Other languages
English (en)
Inventor
Michael John Morser
Charles B Glaser
David Richard Light
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0527821T3 publication Critical patent/DK0527821T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/7455—Thrombomodulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Semiconductor Memories (AREA)
  • Semiconductor Integrated Circuits (AREA)
  • External Artificial Organs (AREA)
  • Paints Or Removers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK91908593.6T 1990-04-09 1991-04-09 Oxidationsresistente thrombomodulinanaloger DK0527821T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/506,325 US5256770A (en) 1990-04-09 1990-04-09 Oxidation resistant thrombomodulin analogs
PCT/US1991/002442 WO1991015514A1 (en) 1990-04-09 1991-04-09 Oxidation resistant thrombomodulin analogs

Publications (1)

Publication Number Publication Date
DK0527821T3 true DK0527821T3 (da) 1997-12-15

Family

ID=24014143

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91908593.6T DK0527821T3 (da) 1990-04-09 1991-04-09 Oxidationsresistente thrombomodulinanaloger

Country Status (11)

Country Link
US (1) US5256770A (da)
EP (1) EP0527821B1 (da)
JP (1) JP3051995B2 (da)
AT (1) ATE153346T1 (da)
AU (1) AU650880B2 (da)
CA (1) CA2077691C (da)
DE (1) DE69126205T2 (da)
DK (1) DK0527821T3 (da)
ES (1) ES2103810T3 (da)
GR (1) GR3024099T3 (da)
WO (1) WO1991015514A1 (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0458903A4 (en) * 1989-02-17 1992-06-17 Codon Soluble analogs of thrombomodulin
US6063763A (en) * 1989-04-28 2000-05-16 Schering Aktiengesellschaft Protease-resistant thrombomodulin analogs
EP0489180A4 (en) * 1990-06-27 1993-03-31 Mochida Pharmaceutical Co., Ltd. Anticoagulant polypeptides
ES2170747T3 (es) * 1990-08-15 2002-08-16 Paion Gmbh Analogos superiores de trombomodulina para uso farmaceutico.
DE69232084T2 (de) * 1991-07-01 2002-05-02 Berlex Lab Neuartige methoden der mutagenese und reagentien dafür
PT641215E (pt) * 1992-02-05 2004-09-30 Paion Gmbh Analogos de trombomodulina resistentes a proteases
DE4323754C1 (de) * 1993-07-15 1994-12-01 Gruenenthal Gmbh Bifunktionelle Urokinasevarianten mit verbesserten fibrinolytischen Eigenschaften und thrombinhemmender Wirkung
US5585095A (en) * 1993-09-14 1996-12-17 Regents Of The University Of Minnesota Method to enhance thrombomodulin APC generation using cationic proteins
DE4440892A1 (de) * 1994-11-17 1996-05-23 Gruenenthal Gmbh Proteine mit fibrinolytischen und gerinnungshemmenden Eigenschaften
ATE361667T1 (de) * 1999-03-23 2007-06-15 Hibernation Therapeutics Ltd Stoppen, schützen und konservieren von organen
US6632791B1 (en) 2000-06-21 2003-10-14 Schering Aktiengesellschaft Thrombomodulin analogs for pharmaceutical use
US20020111296A1 (en) * 2000-08-31 2002-08-15 Festoff Barry W. Thrombomodulin analogs for use in recovery of spinal cord injury
US6706068B2 (en) 2002-04-23 2004-03-16 Bret A. Ferree Artificial disc replacements with natural kinematics
US7579000B2 (en) 2002-05-01 2009-08-25 Bayer Schering Pharma Ag Tissue factor targeted antibodies as anticoagulants
MXPA04010795A (es) * 2002-05-01 2005-03-07 Schering Ag Nuevos anticuerpos dirigidos al factor tisular como anticoagulantes.
AUPS312602A0 (en) * 2002-06-21 2002-07-18 James Cook University Organ arrest, protection, preservation and recovery
WO2004056181A1 (en) * 2002-12-23 2004-07-08 Global Cardiac Solutions Pty Ltd Organ preconditioning, arrest, protection, preservation and recovery (2)
US7833978B2 (en) 2004-02-20 2010-11-16 Emory University Thrombomodulin derivatives and conjugates
WO2006005362A1 (en) * 2004-07-13 2006-01-19 Paion Deutschland Gmbh Production of mammalian proteins in plant cells
AU2005313971B2 (en) * 2004-12-08 2011-10-13 Immunomedics, Inc. Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer
CA2609262A1 (en) 2005-06-03 2006-12-07 Mochida Pharmaceutical Co., Ltd. Anti-cd14 antibody fusion protein
EP2079301B1 (en) 2006-05-29 2017-03-15 Hibernation Therapeutics, a KF LLC Improved tissue maintenance
EP2139316B1 (en) * 2006-07-25 2015-03-18 Hibernation Therapeutics, a KF LLC Trauma therapy
US8541236B2 (en) * 2006-12-08 2013-09-24 University Of Washington Mutant apolipoprotein A-1 polypeptide with increased resistance to oxidation and reactive carbonyls
US20100119554A1 (en) * 2007-03-02 2010-05-13 Hibernation Therapeutics Limited Transplants
AU2008280836A1 (en) * 2007-07-25 2009-01-29 Hibernation Therapeutics, A Kf Llc Improved organ protection, preservation and recovery
EP2120049A1 (de) 2008-05-14 2009-11-18 PAION Deutschland GmbH Lösliches Thrombomodulin als Biomarker bei Therapien mit Gerinnungshemmern
US8241861B1 (en) 2008-07-08 2012-08-14 Insilicos, Llc Methods and compositions for diagnosis or prognosis of cardiovascular disease
CN102481344A (zh) 2009-06-12 2012-05-30 帕昂德国有限公司 具有纤溶亢进的凝血病的治疗
CA2802072A1 (en) 2010-06-14 2011-12-22 Paion Deutschland Gmbh Treatment of coagulopathy with hyperfibrinolysis
KR20130099027A (ko) * 2010-08-05 2013-09-05 카운슬 오브 사이언티픽 앤드 인더스트리얼 리서치 혈전용해 및 응고억제 특성을 갖는 단백질 융합 구조물
WO2014020183A1 (de) 2012-08-03 2014-02-06 Ici Immunochemical Intelligence Gmbh In-vitro-assay zur diagnose von störungen der hämostase
CN105705151A (zh) 2013-07-17 2016-06-22 低温药理Kf有限公司 一种用于治疗出血、休克和脑损伤的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752585A (en) * 1985-12-17 1988-06-21 Cetus Corporation Oxidation-resistant muteins
DE3856335T2 (de) * 1987-01-08 2000-01-27 Asahi Chemical Ind Peptid zur beschleunigung der wirkung des proteins-c mit thrombin
US4835260A (en) * 1987-03-20 1989-05-30 Genetics Institute, Inc. Erythropoietin composition
US4912207A (en) * 1987-05-06 1990-03-27 Washington University DNA clone of human thrombomodulin and portions thereof
DE3824595A1 (de) * 1988-07-19 1990-01-25 Buechler B Set Ag Palette

Also Published As

Publication number Publication date
EP0527821B1 (en) 1997-05-21
DE69126205D1 (en) 1997-06-26
WO1991015514A1 (en) 1991-10-17
AU7778491A (en) 1991-10-30
JP3051995B2 (ja) 2000-06-12
EP0527821A1 (en) 1993-02-24
CA2077691A1 (en) 1991-10-10
EP0527821A4 (en) 1993-05-05
US5256770A (en) 1993-10-26
AU650880B2 (en) 1994-07-07
JPH05508150A (ja) 1993-11-18
ATE153346T1 (de) 1997-06-15
GR3024099T3 (en) 1997-10-31
ES2103810T3 (es) 1997-10-01
DE69126205T2 (de) 1998-08-20
CA2077691C (en) 2001-11-20

Similar Documents

Publication Publication Date Title
DK0527821T3 (da) Oxidationsresistente thrombomodulinanaloger
KR100261030B1 (en) N-terminally chemically modified protein compositions and methods
DE69113663D1 (de) Verbesserungen an implantierbaren vaskularen Anschlussvorrichtungen.
AU557590B2 (en) Aroylimidazolones
PT77898B (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
IL64292A (en) D-homoandrostane-17alpha-carboxylic acids,derivatives thereof and 17alpha-spiroethers,their manufacture and pharmaceutical compositions containing them
DE3486088D1 (de) Einspritzbare physiologisch unbedenkliche polymerzusammensetzungen.
IT8820388A0 (it) Composizione oftalmologica.
IT8921893A0 (it) Procedimento per la produzione di impiallacciatura artificiale ad imitazione della radica, mediante bruciature.
DE69129747T2 (de) In lösung bringen von proteinen in aktiver form
GR73158B (da)
ATE132877T1 (de) Emulgatorfreie emulsionspolymere in pharmazeutischen zubereitungen mit verzögerter wirkstofffreigabe und ihre herstellung
SE9003181D0 (sv) Use of heparin fraction
DE3774715D1 (de) Cardiotonische imidazolylphenylpyrrol-2-one.
ES1000167U (es) Modulo-mueble